A lab-stage mRNA vaccine targeting ticks may offer protection against Lyme and other tick-borne diseases

Published on November 17, 2021

The study found that ticks were unable to feed on guinea pigs vaccinated with an mRNA vaccine, preventing transmission of the pathogen that causes Lyme disease.

Continue reading on website
Other news

Will ETFs Gain on US Industrial Output Rise in October?

November 17, 2021
The latest update on U.S. industrial output looks decent as global economies continue to reopen and the coronavirus outbreak situation improves.

US vaccine rollout was close to optimal at reducing deaths and infections, according to a model comparing 17.5 million alternative approaches

November 17, 2021
With limited vaccines available in early 2021, the CDC had to decide which people received vaccines first. With the help of a supercomputer, researchers have shown that the CDC did...